For years, a central debate in tobacco policy has been whether taxing e-cigarettes (ECs) might unintentionally drive vapers back to traditional cigarettes. A new study published in Health Economics suggests… read more.
While cigarette exposures are decreasing for young children, electronic nicotine products are putting toddlers at new risk of inhalation, according to Rutgers Health researchers. Their study, published in JAMA Network… read more.
GSK plc announced that China’s National Medical Products Administration (NMPA) has approved Exdensur (depemokimab) as add-on maintenance treatment of severe asthma characterised by an eosinophilic phenotype in adult… read more.
A new overview of the best available evidence worldwide for smoking cessation has found that nicotine‑containing e‑cigarettes appear to be more effective for smoking cessation than other interventions… read more.
LivaNova PLC announced the FDA granted premarket approval (PMA) for the aura 6000 System for the treatment of adult patients with moderate to severe Obstructive Sleep Apnea (OSA)…. read more.
The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK has granted a marketing authorisation on on 20 February 2026 to to Insmed Netherlands B.V. for brensocatib (Brinsupri) to… read more.
Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of affordability and lack of knowledge about medications, among other factors, and leads to increased… read more.
Untreated obstructive sleep apnoea may be costing the UK and US economies billions of pounds/dollars in lost productivity every year, with a considerable proportion of working age adults… read more.
New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also… read more.
A universal respiratory syncytial virus (RSV) immunization program using Beyfortus (nirsevimab) was associated with a statistically significant reduction in RSV-related hospitalizations in the second RSV season among infants… read more.
In short-skulled (brachycephalic) dogs, a very flat face, collapsing nostrils, and a plump physique are associated with difficulty breathing, with Pekingeses and Japanese Chins at especially high risk,… read more.
GSK announced that China’s National Medical Products Administration (NMPA) has approved Nucala (mepolizumab) as add-on maintenance treatment of adult patients with inadequately controlled COPD characterised by raised blood… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
